<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: preventive therapy</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Cardio risks need evaluation before prescribing statins</title>
   	 <description>(HealthDay)—Physicians may not adequately consider a patient's cardiovascular risk when prescribing statins as preventive therapy, according to a research letter published online March 11 in JAMA Internal Medicine.</description>
	  <link>http://medicalxpress.com/news/2013-03-cardio-statins.html</link>
	 <category>Cardiology</category>
	 <pubDate>Fri, 15 Mar 2013 13:50:01 EST</pubDate>
	 <guid isPermaLink="false">news282571541</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/cardiorisksn.jpg" width="90" height="96" />
</item>
<item>
     <title>Study examines malaria preventive therapy during pregnancy and outcomes for infants in Africa</title>
   	 <description>Among pregnant women in sub-Saharan Africa, intermittent preventive therapy for malaria with 3 or more doses of the drug regimen sulfadoxine-pyrimethamine was associated with a higher birth weight and lower risk of low birth weight than the current standard 2-dose regimen, according to a review and meta-analysis of previous studies published in the February 13 issue of JAMA.</description>
	  <link>http://medicalxpress.com/news/2013-02-malaria-therapy-pregnancy-outcomes-infants.html</link>
	 <category>Obstetrics &amp; gynaecology</category>
	 <pubDate>Tue, 12 Feb 2013 16:30:07 EST</pubDate>
	 <guid isPermaLink="false">news279906456</guid>
	 
</item>
<item>
     <title>A novel oncogenic network specific to liver cancer initiation</title>
   	 <description>Researchers headed by Erwin Wagner, the Director of the BBVA Foundation-CNIO Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (CNIO), have deciphered how a stress-inducible gene regulator, AP-1, controls the survival of liver tumor-initiating cells. These results, published in the online edition of Nature Cell Biology, could provide new preventive strategies and identify potentially targetable molecules to prevent liver cancer.</description>
	  <link>http://medicalxpress.com/news/2012-10-oncogenic-network-specific-liver-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 07 Oct 2012 14:01:41 EST</pubDate>
	 <guid isPermaLink="false">news268837278</guid>
	 
</item>
<item>
     <title>70,000 children dying every year from tuberculosis: WHO</title>
   	 <description> As many as 70,000 children are dying every year from tuberculosis, as the curable disease often goes unnoticed due to a failure by health workers to recognise the symptoms, the WHO said Wednesday.</description>
	  <link>http://medicalxpress.com/news/2012-03-children-dying-year-tuberculosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 21 Mar 2012 08:20:25 EST</pubDate>
	 <guid isPermaLink="false">news251536816</guid>
	 
</item>
<item>
     <title>Preventive hemophilia A treatment reduces annual bleeding events and frequency of infusions</title>
   	 <description>A Rush University Medical Center led international research team has announced that a treatment to prevent bleeding episodes in children with hemophilia A also is effective for adolescents and adults.</description>
	  <link>http://medicalxpress.com/news/2012-01-hemophilia-treatment-annual-events-frequency.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 09 Jan 2012 11:13:15 EST</pubDate>
	 <guid isPermaLink="false">news245329945</guid>
	 
</item>
<item>
     <title>US urges shorter treatment for TB</title>
   	 <description> US health authorities on Thursday urged a 12-week drug regimen for people with latent tuberculosis as an effective alternative to the current nine-month regimen which many people do not finish.</description>
	  <link>http://medicalxpress.com/news/2011-12-urges-shorter-treatment-tb.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 08 Dec 2011 13:09:46 EST</pubDate>
	 <guid isPermaLink="false">news242572175</guid>
	 
</item>
<item>
     <title>Low risk? Women and young men responsible for large portion of heart attacks</title>
   	 <description>In a contemporary cohort of acute heart attack patients, 70 percent of the patients were unaware they had coronary heart disease (CHD) prior to the event and 60 percent of those patients were women or young men. However, these two subgroups are less likely to qualify for aggressive preventive therapy and, therefore, do not receive preventive medications that could reduce the heart attack risk, according to a study being presented at the American Heart Association (AHA) scientific sessions in Orlando, Fla., on Nov. 16.</description>
	  <link>http://medicalxpress.com/news/2011-11-women-young-men-responsible-large.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 16 Nov 2011 09:42:42 EST</pubDate>
	 <guid isPermaLink="false">news240658953</guid>
	 
</item>
<item>
     <title>Instead of defibrillator's painful jolt, there may be a gentler way to prevent sudden death</title>
   	 <description>Each year in the United States, more than 200,000 people have a cardiac defibrillator implanted in their chest to deliver a high-voltage shock to prevent sudden cardiac death from a life-threatening arrhythmia. While it's a necessary and effective preventive therapy, those who've experienced a defibrillator shock say it's painful, and some studies suggest that the shock can damage heart muscle.</description>
	  <link>http://medicalxpress.com/news/2011-09-defibrillator-painful-jolt-gentler-sudden.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 28 Sep 2011 14:00:04 EST</pubDate>
	 <guid isPermaLink="false">news236432885</guid>
	 
</item>
<item>
     <title>Test measuring blood glucose control may help predict risk of CVD events in patients with diabetes</title>
   	 <description>Measuring hemoglobin A 1c (HbA 1c ) levels in patients with diabetes is associated with improvement in models for predicting risk for cardiovascular disease (CVD), according to a report published Online First today by Archives of Internal Medicine.</description>
	  <link>http://medicalxpress.com/news/2011-07-blood-glucose-cvd-events-patients.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 25 Jul 2011 16:52:20 EST</pubDate>
	 <guid isPermaLink="false">news230831515</guid>
	 
</item>


</channel>
</rss>
